WVE logo

Wave Life Sciences (WVE)

Profile

Full Name

Wave Life Sciences Ltd.

Ticker Symbol

WVE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Singapore

IPO

November 11, 2015

Indexes

Not included

Website

http://wavelifesciences.com

Employees

287

Key Details

Price

$5.65(+3.10%)

Market cap

$867.20M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$108.30M(-4.42% YoY)

Annual EPS

-$0.70(-29.63% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$5.65
WVE price is $5.65

30-Day Relative Volume

0.62
WVE 30-day relative volume is 0.62

Price Performance

Price Most recent change

+3.1%
WVE price was up +3.1% on Apr 11, 2025

Price YTD change

-54.32%
WVE price is down -54.32% since January 1st

Price 1-year change

-5.83%
WVE price is down -5.83% year-on-year

Price 3-year change

+157.99%
WVE price is up +157.99% over the past 3 years

Price Range

Price All-time high

$56.00
WVE price is currently -89.91% below its historical high of $56.00

Price 3-year low

$1.16
WVE price is currently +387.07% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$867.20M
WVE market capitalization is $867.20 million

Market cap 3-year change

+550.64%
WVE market capitalization is up +550.64% over the past 3 years

Market cap All-time high

$2.55B
WVE market capitalization is currently -65.95% below its historical high of $2.55 billion

Market cap sector rank

75.43%
WVE market capitalization is higher than 75.43% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+25.48%
WVE shares outstanding is up +25.48% year-on-year

Shares Outstanding 3-Year Change

+152.2%
WVE shares outstanding is up +152.2% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.46
WVE beta is 1.46

200-day SMA

$9.82
WVE price is currently -42.46% below its 200-day simple moving average

50-day SMA

$9.70
WVE price is currently -41.72% below its 50-day simple moving average

RSI

27.94
WVE 14-day relative strength index is 27.94

Volume

0.62
WVE 30-day relative volume is 0.62

ATR

$0.70
WVE average true range is $0.70

10-day Historical Volatility

104.01%
WVE 10-day historical volatility is 104.01%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$108.30M
WVE annual revenue is $108.30 million

Revenue Analysts estimate

$71.72M
WVE annual revenue is currently +51.00% higher than the consensus analysts' forecast

Revenue 1-year change

-4.42%
WVE annual revenue is down -4.42% year-on-year

Revenue Sector rank

57.11%
WVE annual revenue is higher than 57.11% of companies in Healthcare sector

EPS

EPS

-$0.70
WVE annual earnings per share is -$0.70

EPS Analysts estimate

-$0.92
WVE annual earnings per share is currently -24.15% lower than the consensus analysts' forecast

EPS 1-year change

-29.63%
WVE annual earnings per share is down -29.63% year-on-year

EPS Sector rank

63.5%
WVE annual earnings per share is higher than 63.5% of companies in Healthcare sector

Profit

Gross profit

-
WVE annual gross profit value is unknown

Gross margin

-
WVE annual gross profit margin value is unknown

Operating profit

-$110.40M
WVE annual operating income is -$110.40 million

Operating margin

-101.94%
WVE annual operating profit margin is -101.94%

Net income

-$97.01M
WVE annual net profit is -$97.01 million

Net margin

-89.57%
WVE annual net profit margin is -89.57%

Expenses

Total expenses

$218.71M
WVE annual total expenses is $218.71 million

Operating expenses

$218.71M
WVE annual total operating expenses is $218.71 million

Cost of goods sold

-
WVE annual cost of goods sold value is unknown

Selling, general & administrative expenses

$59.02M
WVE annual SGA is $59.02 million

Depreciation and amortization

$8.66M
WVE annual depreciation & amortization is $8.66 million

Interest expense

-
WVE annual interest expense value is unknown

Income tax

$0.00
WVE annual income tax is $0.00

EBIT & EBITDA

EBIT

-$110.40M
WVE annual earnings before interest & taxes is -$110.40 million

EBITDA

-$101.74M
WVE annual EBITDA is -$101.74 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$352.21M
WVE annual total assets is $352.21 million

Non current assets

$31.81M
WVE annual long term assets is $31.81 million

Current assets

$320.39M
WVE annual total current assets is $320.39 million

Cash and cash equivalents

$302.08M
WVE annual cash & cash equivalents is $302.08 million

Accounts receivable

$1.42M
WVE annual accounts receivable is $1.42 million

Inventory

-
WVE annual inventory value is unknown

Liabilities

Total liabilities

$142.69M
WVE annual total liabilities is $142.69 million

Long term liabilities

$31.74M
WVE annual total long term liabilities is $31.74 million

Current liabilities

$110.95M
WVE annual total current liabilities is $110.95 million

Accounts payable

$16.26M
WVE annual accounts payable is $16.26 million

Debt

Total debt

$25.40M
WVE annual total debt is $25.40 million

Total debt 1-year change

-20.9%
WVE annual total debt is down -20.9% year-on-year

Long term debt

$17.77M
WVE annual long term debt is $17.77 million

Short term debt

$7.64M
WVE annual short term debt is $7.64 million

Equity & Capital

Shareholders equity

$209.51M
WVE annual stockholders equity is $209.51 million

Book value

$209.51M
WVE annual book value is $209.51 million

Retained earnings

-$1.12B
WVE annual retained earnings is -$1.12 billion

Working capital

$209.44M
WVE annual working capital is $209.44 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$151.03M
WVE annual cash flow from operations is -$151.03 million

Cash from operations 1-year change

-677.24%
WVE annual cash flow from operations is down -677.24% year-on-year

Cash from investing

-$938.00K
WVE annual cash flow from investing activities is -$938.00 thousand

Cash from investing 1-year change

+15.87%
WVE annual cash flow from investing activities is up +15.87% year-on-year

Cash from financing

$253.89M
WVE annual cash flow from financing activities is $253.89 million

Cash from financing 1-year change

+91.57%
WVE annual cash flow from financing activities is up +91.57% year-on-year

CAPEX

CAPEX

$938.00K
WVE annual capital expenditures is $938.00 thousand

CAPEX 1-year change

-15.87%
WVE annual capital expenditures is down -15.87% year-on-year

Free Cash Flow

Free cash flow

-$151.96M
WVE annual free cash flow is -$151.96 million

Free cash flow 1-year change

-639.63%
WVE annual free cash flow is down -639.63% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
WVE annual gross profit margin value is unknown

Operating margin

-101.94%
WVE annual operating profit margin is -101.94%

Net margin

-89.57%
WVE annual net profit margin is -89.57%

ROA & ROE

ROA

-30.94%
WVE annual return on assets is -30.94%

ROE

-77.87%
WVE annual return on equity is -77.87%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
WVE price to earnings ratio value is unknown

PE ratio Sector rank

-
WVE price to earnings ratio is unknown

PB Ratio

PB ratio

4.14
WVE price to book ratio is 4.14

PB ratio Sector rank

80.43%
WVE price to book ratio is higher than 80.43% of companies in Healthcare sector

PS Ratio

PS ratio

8.01
WVE price to sales ratio is 8.01

PS ratio Sector rank

75.77%
WVE price to sales ratio is higher than 75.77% of companies in Healthcare sector

Enterprise value

Enterprise value

$590.52M
WVE enterprise value is $590.52 million

Enterprise value Sector rank

70.93%
WVE enterprise value is higher than 70.93% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-5.80
WVE EV/EBITDA is -5.80

EV/EBITDA Sector rank

16.51%
WVE EV/EBITDA is higher than 16.51% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.89
WVE annual current ratio is 2.89

Quick ratio

-
WVE annual quick ratio value is unknown

Leverage

Debt to equity

0.00
WVE annual debt to equity ratio is 0.00

Interest coverage ratio

-
WVE annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
WVE piotroski f-score value is unknown

Altman Z-Score

-0.83
WVE altman z-score is -0.83

Analyst ratings

Recent major analysts updates

Mar 26, 25 HC Wainwright & Co.
Buy
Mar 5, 25 HC Wainwright & Co.
Buy
Feb 25, 25 Jefferies
Buy
Nov 21, 24 Mizuho
Outperform
Nov 13, 24 HC Wainwright & Co.
Buy
Nov 12, 24 Truist Securities
Buy
Nov 4, 24 B. Riley Securities
Buy
Oct 31, 24 HC Wainwright & Co.
Buy
Oct 21, 24 RBC Capital
Sector Perform
Oct 17, 24 JP Morgan
Overweight

Institutional Ownership

Similar stocks

RCUS logo
Arcus Biosciences (RCUS)
MLYS logo
Mineralys Therapeutics (MLYS)
PNTG logo
Pennant (PNTG)
HROW logo
Harrow Health (HROW)
AVAH logo
Aveanna Healthcare Holdings (AVAH)
ESTA logo
Establishment Labs Holdings (ESTA)
GERN logo
Geron (GERN)
STAA logo
STAAR Surgical (STAA)
COLL logo
Collegium Pharmaceutical (COLL)
  • What is the ticker symbol for Wave Life Sciences?
  • Does Wave Life Sciences pay dividends?
  • What sector is Wave Life Sciences in?
  • What industry is Wave Life Sciences in?
  • What country is Wave Life Sciences based in?
  • When did Wave Life Sciences go public?
  • Is Wave Life Sciences in the S&P 500?
  • Is Wave Life Sciences in the NASDAQ 100?
  • Is Wave Life Sciences in the Dow Jones?
  • When was Wave Life Sciences's last earnings report?
  • When does Wave Life Sciences report earnings?
  • Should I buy Wave Life Sciences stock now?

What is the ticker symbol for Wave Life Sciences?

The ticker symbol for Wave Life Sciences is NASDAQ:WVE

Does Wave Life Sciences pay dividends?

No, Wave Life Sciences does not pay dividends

What sector is Wave Life Sciences in?

Wave Life Sciences is in the Healthcare sector

What industry is Wave Life Sciences in?

Wave Life Sciences is in the Biotechnology industry

What country is Wave Life Sciences based in?

Wave Life Sciences is headquartered in Singapore

When did Wave Life Sciences go public?

Wave Life Sciences's initial public offering (IPO) was on November 11, 2015

Is Wave Life Sciences in the S&P 500?

No, Wave Life Sciences is not included in the S&P 500 index

Is Wave Life Sciences in the NASDAQ 100?

No, Wave Life Sciences is not included in the NASDAQ 100 index

Is Wave Life Sciences in the Dow Jones?

No, Wave Life Sciences is not included in the Dow Jones index

When was Wave Life Sciences's last earnings report?

Wave Life Sciences's most recent earnings report was on Mar 4, 2025

When does Wave Life Sciences report earnings?

The next expected earnings date for Wave Life Sciences is May 9, 2025

Should I buy Wave Life Sciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page